Month: May 2025

The Inflation Reduction Act’s (IRA) impact on containing inflation is still debated. However, certain provisions have delivered significant benefits, particularly in strengthening U.S. energy production through renewable energy innovation. Tax credits for energy generation are driving substantial investment in innovative energy production, benefiting the entire industry and sustaining ratepayer costs. These investments have created construction … Read more

ZDNET Recommends is based on extensive testing, research, and comparison shopping to provide unbiased recommendations. We gather data from various sources, including vendor listings and independent reviews sites, to ensure our content is accurate and informative. When you click through to purchase a product or service from ZDNET, we may earn affiliate commissions, but it … Read more

Cardiac deaths are increasing globally, with more people dying at home rather than in hospitals, despite lower hospital admissions. Researchers from Mass General Brigham studied death certificate data and found that cardiac deaths exceeded expected levels between 2020 and 2023, particularly among those who died at home. The study, published in JAMA Network Open, used … Read more

To resolve issues with automatic login for browser notifications, users can try two simple solutions. Firstly, checking and updating browser preferences can help manage notifications more effectively. Users can do this by navigating to their browser’s settings or options. Alternatively, simply refreshing the page or switching to another page on the site can automatically log … Read more

Taylor Swift has finally regained control over her entire music catalogue after buying back the master recordings of her first six albums from private equity firm Shamrock Capital. The singer-songwriter, who had lost the rights to her music in 2019 when her former record label Big Machine sold them to music executive Scooter Braun, expressed … Read more

Summit Therapeutics’ ivonescimab, a PD1-VEGF antibody, has failed to demonstrate a survival benefit for patients with lung cancer. Despite showing promise in delaying disease progression in U.S. and Western countries, the results are inconsistent with those seen in Chinese patients enrolled in earlier trials. The drug’s performance has raised concerns about its potential as a … Read more

The role of pharmacists in supporting long-term weight management with GLP-1 therapies has become increasingly important. Dr. Katherine H. Saunders, an obesity physician and co-founder of FlyteHealth, emphasizes the need for comprehensive care strategies that combine pharmacotherapy with sustainable lifestyle interventions. To achieve long-term weight maintenance and reduce cardiovascular disease risks, evidence-based dietary and physical … Read more

ISIS (ISIL) has launched its first attacks against the new Syrian government, targeting a convoy in southern Syria and killing or wounding seven soldiers. The bombings mark a sharp escalation by the armed group, which views the new government as illegitimate. Analysts say this is ISIS’s first strike at government forces since the fall of … Read more

Summit Therapeutics, a China-focused biotech firm, recently reported positive results from a clinical trial of its cancer immunotherapy. The study aimed to answer a pressing question in the industry: how do Chinese-developed cancer treatments perform when tested in western countries. Summit’s SMMT-101, an experimental cancer treatment, showed significant efficacy in a Phase II trial. This … Read more

The US economy slowed down in April as consumers reduced their spending, while goods imports plummeted by a record due to higher tariffs. Inflation-adjusted personal spending rose 0.1% from the previous month’s 0.7%, according to Bureau of Economic Analysis data. This slowdown was accompanied by an almost 20% decline in imports, which significantly narrowed the … Read more